NCT03802058 - Concurrent Nab-P/Carboplatin and Thoracic Radiotherapy in Squamous Cell Lung Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 20, 2019

Primary Completion Date

December 12, 2021

Study Completion Date

December 12, 2021

Conditions

Carcinoma, Non-Small-Cell LungSquamous Cell Carcinoma

Interventions

DRUG

Nab-paclitaxel

Nab-paclitaxel 40mg/m2 for Injection weekly

DRUG

Carboplatin

Carboplatin AUC=2 for Injection weekly

RADIATION

Thoracic radiation therapy

Thoracic radiation therapy 60-66Gy/30-33 fractions,both three-dimensional conformal and intensity modulated radiation therapy are allowed

Trial Locations (1)

Zhongnan Hospital of Wuhan University, Wuhan